SCHEMBL26211337

SCHEMBL26211337

CN(C(=O)CCO)C1CCCCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
BACE1 P56817 1/20 0.43
FAAH O00519 1/20 0.42
PHGDH O43175 1/20 0.42
MGLL Q99685 1/20 0.42
PKM P14618 1/20 0.42
NPBWR1 P48145 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ATM Q13315 1/20 0.40
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE5A O76074 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26211329 1.00 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL26211334 1.00 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL26211327 0.98 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL26211324 0.96 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL26211323 0.90 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL10723835 0.90 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL5143783 0.88 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL10453317 0.86 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL10722325 0.86 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1NPSR1BACE1
SCHEMBL10721996 0.84 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1NPSR1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT ALDH1A1 4587/4885KMT2A 2694/4885MEN1 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.